首页> 外国专利> Genetically modified non-human animals for generating therapeutic antibodies against peptide-MHC complexes, methods of making and uses thereof

Genetically modified non-human animals for generating therapeutic antibodies against peptide-MHC complexes, methods of making and uses thereof

机译:用于产生针对肽-MHC复合物的治疗性抗体的转基因非人类动物,其制备方法和用途

摘要

A non-human animal is genetically modified with sequence encoding a human or humanized MHC molecule or associated molecule, e.g., β2 microglobulin, and expression of the sequence by the non-human animal induces tolerance to the corresponding human HLA from which the human or human MHC molecule is derived. The tolerance exhibited by these non-human animals allows these animals to generate specific antibody responses to the corresponding human HLA when such HLA is presenting a peptide that is antigenic to the non-human animal. Such an antibody response, which specifically targets a pMHC complex of interest without binding to the MHC molecule may be useful in immunotherapeutic modalities that target a component of the immunological synapse which provides the specificity of that interaction.
机译:用编码人或人源化的MHC分子或相关分子(例如β2微球蛋白)的序列对非人类动物进行遗传修饰,并且该非人类动物对该序列的表达可诱导其对相应人类HLA的耐受性MHC分子是衍生的。这些非人类动物表现出的耐受性使这些动物对相应的人类HLA产生特异性抗体反应,而这种HLA呈现的是对非人类动物具有抗原性的肽。这种特异性靶向目标pMHC复合物而不结合MHC分子的抗体反应可用于靶向提供这种相互作用特异性的免疫突触成分的免疫治疗方式。

著录项

  • 公开/公告号AU2019242551A1

    专利类型

  • 公开/公告日2020-10-22

    原文格式PDF

  • 申请/专利权人 REGENERON PHARMACEUTICALS INC.;

    申请/专利号AU20190242551

  • 发明设计人 MURPHY ANDREW J.;

    申请日2019-03-22

  • 分类号A01K67/027;C07K14/74;C07K16;

  • 国家 AU

  • 入库时间 2022-08-21 11:11:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号